Key result
Myocardial revascularization in patients with chronic left ventricular systolic dysfunction lacks clear prognostic evidence, highlighting the need for future randomized trials.
Why the study?
Does myocardial revascularization improve prognosis in patients with chronic left ventricular systolic dysfunction due to coronary artery disease on optimal medical therapy?
Does myocardial revascularization improve prognosis in patients with chronic left ventricular systolic dysfunction due to coronary artery disease on optimal medical therapy?
The paper highlights the ongoing need for randomized trials to determine the prognostic benefits of coronary revascularization in patients with ischemic left ventricular systolic dysfunction receiving optimal medical therapy.
Revascularization should not yet alter practice for prognosis in ischemic LV systolic dysfunction on OMT; leaves open whether RCTs will demonstrate benefit.
Outcomes of myocardium revascularization in patients with chronic left ventricular systolic dysfunction due to coronary artery disease are still unclear. The identi fi cation of dysfunctional myocardial with residual viability that can improve after revascularization are very important for further patient treatment. Hibernating myocardium can be identi fi ed by different methods and its presence and extent can predict functional and structural recovery after revascularization. New medical treatments and devices, have improved the prognosis of this patients and their use is supported by a number of clinical trials. The prognostic bene fi ts of coronary revascularization for patients with chronic left ventricular dysfunction on optimal medical therapy and novel devices a randomized trial is still needed.
No takes yet. Share an insight, caveat, or question.
Б. Л. Миронков (2014) conducted a review in Chronic left ventricular systolic dysfunction due to coronary artery disease. Myocardial revascularization vs. Optimal medical therapy was evaluated. Myocardial revascularization in patients with chronic left ventricular systolic dysfunction lacks clear prognostic evidence, highlighting the need for future randomized trials.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: